Bagmane Pharmaceuticals Profile
Key Indicators
- Authorised Capital ₹ 2.00 Cr
as on 05-12-2024
- Paid Up Capital ₹ 0.83 M
as on 05-12-2024
- Company Age 37 Year, 5 Months
- Last Filing with ROC 31 Mar 2023
- Revenue -82.81%
(FY 2016)
- Profit 49.88%
(FY 2016)
- Ebitda 69.04%
(FY 2016)
- Net Worth -6.61%
(FY 2016)
- Total Assets -10.70%
(FY 2016)
About Bagmane Pharmaceuticals
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 2.00 Cr and a paid-up capital of Rs 0.83 M, as per Ministry of Corporate Affairs (MCA) records.
Dandiganahalli Venkataramanappa and Raja Bagmane serve as directors at the Company.
- CIN/LLPIN
U02423KA1987PTC008494
- Company No.
008494
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
20 Jul 1987
- Date of AGM
30 Sep 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Bangalore
Industry
Company Details
- Location
Bangaluru, Karnataka, India
- Telephone
- Email Address
- Website
- Social Media
Who are the key members and board of directors at Bagmane Pharmaceuticals?
Board Members(2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Dandiganahalli Venkataramanappa  | Director | 15-Feb-2010 | Current |
| Raja Bagmane | Director | 20-Jul-1987 | Current |
Financial Performance of Bagmane Pharmaceuticals.
Bagmane Pharmaceuticals Private Limited, for the financial year ended 2016, experienced significant reduction in revenue, with a 82.81% decrease. The company also saw a substantial improvement in profitability, with a 49.88% increase in profit. The company's net worth dipped by a decrease of 6.61%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Bagmane Pharmaceuticals?
In 2017, Bagmane Pharmaceuticals had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Bagmane Constructions Private LimitedActive 19 years 9 monthsDandiganahalli Venkataramanappa and Raja Bagmane are mutual person
- Akruthi Infra-Build Developers Private LimitedActive 14 years 10 months
Dandiganahalli Venkataramanappa and Raja Bagmane are mutual person
- Vaigai Investments Private LimitedActive 41 years 6 months
Dandiganahalli Venkataramanappa and Raja Bagmane are mutual person
- Bagmane Developers Private LimitedActive 28 years 11 months
Dandiganahalli Venkataramanappa and Raja Bagmane are mutual person
- Bagmane Properties Private LimitedActive 15 years 1 month
Dandiganahalli Venkataramanappa and Raja Bagmane are mutual person
- S.B.G. Software Private LimitedActive 24 years 2 months
Dandiganahalli Venkataramanappa and Raja Bagmane are mutual person
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Bagmane Pharmaceuticals?
Unlock and access historical data on people associated with Bagmane Pharmaceuticals, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Bagmane Pharmaceuticals, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Bagmane Pharmaceuticals's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
